Rapid Emergence of Emm84 Among Invasive Streptococcus Pyogenes Infections in Finland

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2008 Dec 17

PMID 19073871

Citations 7

Authors

Tuula Siljander

Outi Lyytikainen

Susanna Vahakuopus

Petrus Saila

Jari Jalava

Jaana Vuopio-Varkila

Affiliations

Soon will be listed here.

Abstract

From 2005 to 2007, in Finland, the incidence of invasive Streptococcus pyogenes disease increased sharply, partly due to the uncommon emm84 gene becoming more prevalent from 2006 onwards. The overall case fatality rate of infections caused by strains carrying emm84 was not significantly different than that of infections caused by other types (7% versus 10%, respectively; P = 0.50).

Citing Articles

Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.

Latronico F, Nasser W, Puhakainen K, Ollgren J, Hyyrylainen H, Beres S J Infect Dis. 2016; 214(12):1987-1995.

PMID: 27707808 PMC: 5142090. DOI: 10.1093/infdis/jiw468.

Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.

Smit P, Lindholm L, Lyytikainen O, Jalava J, Patari-Sampo A, Vuopio J Eur J Clin Microbiol Infect Dis. 2015; 34(10):2131-6.

PMID: 26292935 DOI: 10.1007/s10096-015-2462-2.

Invasive group a streptococcal disease: epidemiology, pathogenesis and management.

Steer A, Lamagni T, Curtis N, Carapetis J Drugs. 2012; 72(9):1213-27.

PMID: 22686614 PMC: 7100837. DOI: 10.2165/11634180-000000000-00000.

Distribution of emm types in invasive and non-invasive group A and G streptococci.

Vahakuopus S, Vuento R, Siljander T, Syrjanen J, Vuopio J Eur J Clin Microbiol Infect Dis. 2011; 31(6):1251-6.

PMID: 22002182 DOI: 10.1007/s10096-011-1436-2.

Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Rantala S, Vahakuopus S, Siljander T, Vuopio J, Huhtala H, Vuento R Eur J Clin Microbiol Infect Dis. 2011; 31(5):859-65.

PMID: 21877175 DOI: 10.1007/s10096-011-1385-9.

References

Eriksson B, Andersson J, Holm S, Norgren M . Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis. 1999; 180(2):410-8. DOI: 10.1086/314872. View

Zachariadou L, Papaparaskevas J, Paraskakis I, Efstratiou A, Pangalis A, Legakis N . Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children. Clin Microbiol Infect. 2003; 9(4):310-4. DOI: 10.1046/j.1469-0691.2003.00493.x. View

Kotloff K, Corretti M, Palmer K, Campbell J, Reddish M, Hu M . Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004; 292(6):709-15. DOI: 10.1001/jama.292.6.709. View

OLoughlin R, Roberson A, Cieslak P, Lynfield R, Gershman K, Craig A . The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007; 45(7):853-62. DOI: 10.1086/521264. View

McNeil S, Halperin S, Langley J, Smith B, Warren A, Sharratt G . Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005; 41(8):1114-22. DOI: 10.1086/444458. View

Cohen-Poradosu R, Kasper D . Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis. 2007; 45(7):863-5. DOI: 10.1086/521263. View

Maripuu L, Eriksson A, Norgren M . Superantigen gene profile diversity among clinical group A streptococcal isolates. FEMS Immunol Med Microbiol. 2008; 54(2):236-44. DOI: 10.1111/j.1574-695X.2008.00469.x. View

Tewodros W, Kronvall G . M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol. 2005; 43(9):4369-76. PMC: 1234087. DOI: 10.1128/JCM.43.9.4369-4376.2005. View

Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W . Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol. 2006; 44(11):3975-9. PMC: 1698320. DOI: 10.1128/JCM.01163-06. View

10.

Richter S, Heilmann K, Beekmann S, Miller N, Miller A, Rice C . Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis. 2005; 41(5):599-608. DOI: 10.1086/432473. View

11.

Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhoj P . Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol. 2005; 43(7):3101-9. PMC: 1169105. DOI: 10.1128/JCM.43.7.3101-3109.2005. View

12.

Moody M, PADULA J, LIZANA D, HALL C . EPIDEMIOLOGIC CHARACTERIZATION OF GROUP A STREPTOCOCCI BY T-AGGLUTINATION AND M-PRECIPITATION TESTS IN THE PUBLIC HEALTH LABORATORY. Health Lab Sci. 1965; 2:149-62. View

13.

Hoe N, Kordari P, Cole R, Liu M, Palzkill T, Huang W . Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis. 2000; 182(5):1425-36. DOI: 10.1086/315882. View

14.

Stevens D, Tanner M, Winship J, Swarts R, Ries K, Schlievert P . Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989; 321(1):1-7. DOI: 10.1056/NEJM198907063210101. View

15.

Krucso B, Gacs M, Libisch B, Hunyadi Z, Molnar K, Fuzi M . Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur J Clin Microbiol Infect Dis. 2007; 26(11):807-11. DOI: 10.1007/s10096-007-0359-4. View

16.

Lamagni T, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G . Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis. 2008; 14(2):202-9. PMC: 2600190. DOI: 10.3201/eid1402.070888. View

17.

Siljander T, Karppelin M, Vahakuopus S, Syrjanen J, Toropainen M, Kere J . Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis. 2008; 46(6):855-61. DOI: 10.1086/527388. View

18.

Siljander T, Toropainen M, Muotiala A, Hoe N, Musser J, Vuopio-Varkila J . emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J Med Microbiol. 2006; 55(Pt 12):1701-1706. DOI: 10.1099/jmm.0.46690-0. View

19.

Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G . Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis. 1995; 21(5):1220-7. DOI: 10.1093/clinids/21.5.1220. View

20.

Johnson D, Kaplan E, VanGheem A, Facklam R, Beall B . Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol. 2006; 55(Pt 2):157-164. DOI: 10.1099/jmm.0.46224-0. View